Teva in Ireland
The chances are, someone you know is living a healthier life because of our medicines; after all we are the largest supplier of prescription medicines to Irish pharmacies. 01
Teva is a global pharmaceutical company serving 200 million people every day. 02
At this moment:
- An Irish parent is trusting a Teva medicine to help a sick child get well.
- An Irish doctor is writing a prescription for a Teva medicine, to improve her patient’s outcome.
- An Irish pharmacist is reaching for a Teva product, secure in the knowledge that Teva medicines meet the highest standards for quality and safety.
Teva is committed to providing medicines that serve people around the world, both prescription medications as well as over-the-counter treatments. We offer high-quality generic and specialty medicines to patients across a wide range of therapeutic areas. And, we are continually expanding our range of products and services to better meet the needs of Irish patients and healthcare professionals.
Teva - A key partner to the Irish Health Service
Like all health systems globally, the Health Service Executive is under huge pressure from rising patient demand from an aging population, often managing multiple chronic conditions and rising costs. At Teva we're working hard to help the HSE do more with less by driving sustainability and value through our range of generic medicines and innovative medicines.
We’re focused on improving how long-term conditions are managed, addressing cost-efficient prescribing and ensuring high quality joined-up care for the patient. We're also looking at healthcare options that are fit for the future, like new technologies, innovative devices, and a fresh approach to services.
Teva employs around 800 people in Ireland and has three sites in the Republic of Ireland and one site in Northern Ireland.
Teva’s commercial activities span the sales and support services for Teva’s large portfolio of medicines, both generics and branded innovative medicines, along with over-the-counter consumer health products.
We supply medicines to treat a wide range of diseases and conditions – from multiple sclerosis, asthma, cancer and Chronic Obstructive Pulmonary Disease, to pain relief, cholesterol reducers and antibiotics. Dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions, suspensions and inhalers.
Whether they’re used in hospitals or by GPs, nurses, or independent pharmacists, our medicines are supported by comprehensive advice and information from our Medical teams.
In additional to the field-based sales teams covering both primary and secondary care in Ireland; Teva’s commercial teams and support functions are based in Swords, near Dublin.
Research and Manufacturing
Teva is a major employer in Ireland with hundreds of highly skilled staff working in our Research and Development and manufacturing facilities.
The Waterford site is of major strategic importance within the Teva manufacturing network and is responsible for the manufacture and development of respiratory products for supply to the United States and around 30 other global markets. It includes an onsite research and development centre.
Since 1985 Teva has invested significantly in the market leading technologies to manufacture metered dose inhalers (MDIs) and breath-actuated inhalers such as Teva’s Spiromax® device.
The Waterford site quality standards are recognised as the gold standard within Teva. The site is FDA approved (which means we are approved to export our products to the US, by US’s Food and Drug Administration (FDA)).
The research and development focus at Waterford is dedicated to the next generation respiratory products for the treatment of respiratory conditions like asthma and Chronic Obstructive Pulmonary Disease.
Since 1984 Baldoyle has been a manufacturing site for the over-the-counter medication Sudocrem®, first developed in 1931 and now a multi-award winning, globally recognised product sold in over 50 countries.
Sudocrem® Antiseptic Healing Cream is an absolute staple in Irish households, loved by Irish families for its ability to soothe cuts, grazes, bed sores, sunburn, eczema as well as nappy rash.
In fact, Sudocrem® is the top selling nappy rash product in 15 countries.
Developed in 1931 to treat nappy rash by Dublin pharmacist Thomas Smith, the classic formula has remained unchanged and the 34.4 million pots sold worldwide every year are still manufactured in Baldoyle, Dublin.
Positively Impacting Ireland's Economy
As an employer and a manufacturer, Teva creates jobs and contributes to economic output. Beyond direct expenditures, Teva's spending initiates a series of income creation, spending and re-spending that support other jobs and contribute to additional Gross Domestic Product (GDP).
Teva's economic impact in 2018 included supporting more than 1,200 full-time jobs, contributing €351 million ($425 million) to GDP and generating €68 million ($83 million) in labour income, a measure of aggregate worker wages. 03
Back to contents.
Teva Ireland – Data on file
Back to contents.
Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers. Ref 2.1 dated August 2016; Ref 2.2 dared April 2019
Back to contents.
Teva Economic Impact Report - Matrix Global Advisors estimate of Teva’s Macroeconomic Impact in Ireland in 2018